-
-
GLP-1 Side Chains
显示更多 -
Peptide Intermediates
-
Fmoc-His-Aib-OH
-
Fmoc-Ile-Aib-OH
-
Fmoc-Tyr(tBu)-Aib-OH
-
Fmoc-Glu(OtBu)-Aib-OH
-
Fmoc-His(Fmoc)-Aib-OH
-
Fmoc-His(Fmoc)-Aib-OSu
显示更多 -
-
Tirzepatide Fragments
-
CAS:2682040-93-1
-
CAS:3034670-52-2
-
CAS:1262308-37-1
-
CAS:2461524-68-3
-
CAS:2656383-24-1
-
CAS:2656383-25-2
显示更多 -
-
API & Excipients
显示更多 -
Cosmetic Peptides
-
Oligopeptide-1
-
NonaPeptide-1
-
Copper Tripeptide-1
-
Acetyl Hexapeptide-8
-
Palmitoyl Tripeptide-1
-
Decarboxy Carnosine HCl
显示更多 -
-
Active Ingredients
显示更多
-

Platform
EMPHASES® Peptide Synthesis Platform
Obtained 5 Chinese patents, 1 US patent, and 1 Japanese patent.
Replace traditional insoluble resins with soluble carriers in peptide synthesis.
Increase reaction speed, shorten duration and improve synthesis efficiency.
Reduce the consumption(amino acids, reagents & solvent), minimize waste and cut manufacturing costs.
Application:
Pharmaceutical Peptides
Cosmetic Peptides
Peptide Fragments

Stability

Potentiation

Delivery
Established five advanced technology platforms aimed at overcoming formulation challenges.
For example, designed through the Inactiv nano-locking platform can inhibit P-glycoprotein activity, reduce the efflux of active substances within cells, and significantly enhance efficacy. Such as oil-soluble anti-wrinkle peptide and Resveratrol Pro.
Hydractiv: Water-solubility Synergy Application Platform
It successfully solved the poor water solubility of components such as ferulic acid and salicylic acid.
It also enhances their efficacy and offers greater flexibility in formulation design.
Sorry,当前栏目暂无内容!
您可以查看其他栏目或返回 首页
Sorry,The current column has no content!
You can view other columns or return Home